Immunokick Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

Immunokick General Information

Description

Producer of monoclonal antibodies. The company's monoclonal antibodies are used for development and marketing of medicinal products, medicaments for animals, cosmetics, agricultural chemicals, food items, and reagents, enabling pharmaceutical companies to develop antibody drugs, clinical diagnostic products, assay systems with antibodies.

Contact Information

Website
www.immunokick.co.jp
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 30-69 1-chome, Takahira
  • Kumamoto
  • Japan
Primary Industry
Biotechnology
Corporate Office
  • 30-69 1-chome, Takahira
  • Kumamoto
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunokick Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunokick‘s full profile, request access.

Request a free trial

Immunokick Patents

  • 19

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • Pending

  • Expiring in next 12 mo

Immunokick Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080233109-A1 Germinal center-associated nuclear protein (ganp); high affinity antibody Inactive 07-Nov-2002
US-20060236417-A1 Germinal center-associated nuclear protein (ganp); high affinity antibody; humanizing Active 07-Nov-2002
US-7919674-B2 Germinal center-associated nuclear protein (ganp); high affinity antibody; humanizing Inactive 07-Nov-2002
DE-60327094-D1 Transgene mammal, wearing in this inged ganp genes, and its use Inactive 07-Nov-2002
AU-2003277620-A1 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof Active 07-Nov-2002 A01K67/0275
To view Immunokick’s complete patent history, request access »

Immunokick Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunokick FAQs

  • When was Immunokick founded?

    Immunokick was founded in 2004.

  • Where is Immunokick headquartered?

    Immunokick is headquartered in Kumamoto, Japan.

  • What is the size of Immunokick?

    Immunokick has 1 total employees.

  • What industry is Immunokick in?

    Immunokick’s primary industry is Biotechnology.

  • Is Immunokick a private or public company?

    Immunokick is a Private company.

  • What is the current valuation of Immunokick?

    The current valuation of Immunokick is .

  • What is Immunokick’s current revenue?

    The current revenue for Immunokick is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process